Full-Time
Site Technology Specialist
PSI CRO
1,001-5,000 employees
No salary listed
United States
In Person
Role requires on-site support at clinical sites with periodic travel within the United States.
 Biology & Biotech (1) |
|---|
- Previous experience (5+ years) as a nuclear medicine technologist
- Experience in operation and QC procedures related to the equipment used in the specialized area
- RN, LPN, or equivalent associate degree
- Provides clinical sites with technical support and expertise related to technology.
- Assists in the design and implementation of study related forms, guidelines and manuals related to technologies.
- Coordinates data collection related to technologies, including but not limited to nuclear medicine, radiology, etc.
- Provides technical and initiation support to sites.
- Identifies, tracks, and reports specific technical timepoints in the study related to study procedures including imaging, scans, and other technologies.
- Determines technical resources needed for project implementation, and communicates needs to department managers.
- Organizes technical training for project teams.
- Provides support to the project teams to ensure proper documentation of study-specific assessments related to study technologies.
- Supports site initiation preparation and performs technical visits to assist the site team with technical aspects of the study.
- Assists and advises the site monitor in the area of study technologies.
- Provides relevant technology-related information to Business Development for proposals.
- MRI experience
- Clinical trial experience is a plus
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Switzerland
Founded
1995
Simplify's Take
What believers are saying
- China's rising global clinical role boosts demand for PSI's Beijing and Shanghai local expertise.
- Toronto office with David Allen strengthens North American Phase II/III trial execution.
- Sayaka Kaji's March 2025 Japan appointment deepens Asia-Pacific operational leadership.
What critics are saying
- China regulators restrict PSI's Shanghai and Beijing offices within 12-24 months.
- Arango platform outage erodes SYNETIC site selection edge in 6-18 months.
- IQVIA outcompetes PSI in Japan, limiting Asia-Pacific trial wins in 12-24 months.
What makes PSI CRO unique
- SYNETIC AI cuts site selection from 6 weeks to minutes, avoiding 30-40% non-enrolling sites.
- Beijing office opened April 2026 near China's regulatory authorities and top investigator sites.
- CRA Academy builds therapeutic expertise, reducing staff turnover on client projects.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at PSI CRO who can refer or advise you
Benefits
Health Insurance
Paid Vacation
Flexible Work Hours
Hybrid Work Options
Remote Work Options
Wellness Program
Mental Health Support
Conference Attendance Budget
Professional Development Budget
Company News
PSI CRO, a global clinical research organisation, has reduced clinical trial site identification from up to six weeks to minutes using SYNETIC, an AI knowledge engine powered by the Arango Contextual Data Platform. The system helps identify higher-performing trial sites and minimise costly non-enrolling institutions, which account for 30-40% of trial sites. Clinical trials can cost over $160 per minute operationally, and activating a trial site costs $30,000 or more. With 15% of sites never enrolling a single patient, failed recruitment can cost millions per study. SYNETIC unifies fragmented clinical research data into a single contextual layer, preserving relationships across investigators, institutions, protocols and historical outcomes. The platform provides explainable AI recommendations, including rationale, supporting evidence and confidence levels, enabling data-driven site selection in minutes rather than weeks.
PSI CRO strengthens Canadian presence with new Toronto office and leadership role. PSI CRO has broadened its footprint in Canada by opening a new office in the Toronto area and naming an experienced industry leader to guide its operations there. The office, located in Mississauga, Ontario, builds on the company's established Canadian presence and commitment to clinical research excellence. PSI CRO has been active in Canada for over a decade, supporting complex clinical trials with a focus on dependable delivery and strong relationships with research sites. As part of this expansion, David Allen, MBA, has been appointed as Country Manager for Canada. Allen brings more than 30 years of experience in clinical research from both sponsor and CRO environments. In his new role, he will lead efforts to enhance the company's operational capabilities in the local market and ensure alignment with PSI's global standards for on-time trial execution. PSI's continued growth in North America reflects broader trends of increasing trial activity in the region, particularly for pivotal phase II and phase III studies where precision and efficiency are critical. The expanded Toronto operations aim to further support sponsors with rigorous trial planning and execution.
TOKYO, 14 March 2025 - PSI CRO AG, a global Swiss-based clinical research organization (CRO), is pleased to announce the appointment of Sayaka Kaji as Country Manager for Japan.
Psi CRO Ag launched a CRA Academy to provide to help its team members develop therapeutic expertise as well as soft skills to manage key relationships with sites.
This is also the fourth year in a row in which PSI CRO received CRO Leadership Awards in all five categories, also including Expertise and Capabilities, across two respondent groups.